Home / SLC35A4 Knockout Cell Lines

SLC35A4 Knockout Cell Lines

Gene: SLC35A4

Official Full Name: solute carrier family 35 member A4provided by HGNC

Gene Summary: Predicted to enable transmembrane transporter activity. Involved in positive regulation of cellular respiration and positive regulation of translation in response to stress. Located in Golgi membrane and mitochondrial inner membrane. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO30810 SLC35A4 Knockout cell line (HeLa) Human SLC35A4 1:3~1:6 Negative Online Inquiry
KO30811 SLC35A4 Knockout cell line (HCT 116) Human SLC35A4 1:2~1:4 Negative Online Inquiry
KO30812 SLC35A4 Knockout cell line (HEK293) Human SLC35A4 1:3~1:6 Negative Online Inquiry
KO30813 SLC35A4 Knockout cell line (A549) Human SLC35A4 1:3~1:4 Negative Online Inquiry

Background

SLC35A4 Gene Knockout Cell Lines are genetically modified cell models created to effectively investigate the functional implications of the SLC35A4 gene, known to be involved in nucleotide sugar transport and essential for glycosylation processes. These knockout cell lines have been generated through advanced genome editing techniques, particularly CRISPR-Cas9, leading to the precise inactivation of the SLC35A4 gene, which allows researchers to study the effects of its absence on various physiological and pathological processes.

The primary mechanism by which SLC35A4 functions involves the transport of nucleotide sugars across cellular membranes, which are critical for glycoprotein and glycolipid synthesis. The SLC35A4 knockout cell lines provide a valuable tool for dissecting pathways associated with glycosylation defects, enabling researchers to explore cellular processes such as cell signaling, immune responses, and developmental biology at a higher resolution. This model is particularly relevant in studying diseases where glycosylation anomalies play a significant role, such as congenital disorders of glycosylation (CDGs) and certain cancers.

In comparison to other knockout models, SLC35A4 Gene Knockout Cell Lines are unique due to their specific focus on glycosylation-related research, which is often overlooked in broader studies. The precision of the CRISPR technology ensures that the gene is inactivated without off-target effects, providing a reliable platform for experimental reproducibility. The ease of culture and maintenance of these cell lines further enhances their value, allowing researchers to devote more time to experimental design and data analysis.

For researchers, clinicians, and pharmaceutical companies, the SLC35A4 Gene Knockout Cell Lines are an indispensable resource for elucidating the underlying mechanisms of diseases linked to glycosylation errors, paving the way for the development of targeted therapies. With a commitment to excellence, our company specializes in providing high-quality biological products that facilitate cutting-edge research, ensuring that our users have the most reliable tools for advancing scientific discovery.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.